U.S. Physical Therapy (USPH) Stock Price, News & Analysis

Company Overview

U.S. Physical Therapy, Inc. (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S. Physical Therapy offers specialized treatments such as dry needling, balance and fall-prevention programs, athletic training and industrial rehabilitation. The company has also developed telehealth capabilities to extend its reach and improve access for patients who face geographical or mobility constraints. U.S. Physical Therapy works with a broad network of referring physicians, hospitals and managed care organizations to coordinate patient care and facilitate seamless transitions between inpatient and outpatient settings.

Founded in 1990 and headquartered in Harrisburg, Pennsylvania, U.S. Physical Therapy has grown through a combination of organic clinic openings and strategic acquisitions. Today, the company operates over 800 clinics in more than 40 states, serving both urban and rural markets. Its decentralized management model empowers local clinical teams while maintaining standardized care protocols and operational best practices. U.S. Physical Therapy’s leadership team draws on decades of healthcare and rehabilitation experience to drive growth, enhance patient outcomes and maintain high standards of clinical excellence.

Key Stats

• Today's Range: $61.80 to $62.95
• 50-Day Range: $59.11 to $78.42
• 52-Week Range: $58.19 to $93.50
• Volume: 92,133 shs
• Average Volume: 206,108 shs
• Market Capitalization: $936.79 million
• P/E Ratio: 123.43
• Dividend Yield: 2.99%
• Price Target: $97.50
• Consensus Rating: Moderate Buy

U.S. Physical Therapy Stock Analysis - MarketRank™

U.S. Physical Therapy scored higher than 87% of companies evaluated by MarketBeat, and ranked 75th out of 857 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

U.S. Physical Therapy has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 1 strong buy rating, 4 buy ratings, 2 hold ratings, and no sell ratings.

Upside Potential

U.S. Physical Therapy has a consensus price target of $97.50, representing about 57.5% upside from its current price of $61.91.

Amount of Analyst Coverage

U.S. Physical Therapy has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 15.72%

Earnings Growth

Earnings for U.S. Physical Therapy are expected to grow by 15.72% in the coming year, from $2.99 to $3.46 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of U.S. Physical Therapy is 123.82, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.74.

Price to Earnings Ratio vs. Sector

The P/E ratio of U.S. Physical Therapy is 123.82, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.54.

Price to Earnings Growth Ratio

U.S. Physical Therapy has a PEG Ratio of 1.69. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

U.S. Physical Therapy has a P/B Ratio of 1.97. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.03% of the float of U.S. Physical Therapy has been sold short.

Short Interest Ratio / Days to Cover

U.S. Physical Therapy has a short interest ratio ("days to cover") of 4.66.

Change versus previous month

Short interest in U.S. Physical Therapy has recently increased by 12.35%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

U.S. Physical Therapy pays a meaningful dividend of 3.00%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

U.S. Physical Therapy has been increasing its dividend for 6 years.

Dividend Coverage

The dividend payout ratio of U.S. Physical Therapy is 368.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 53.18% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: N/A

News Sentiment

U.S. Physical Therapy has a news sentiment score of 1.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.76 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for U.S. Physical Therapy this week, compared to 3 articles on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, U.S. Physical Therapy insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $52,205.00 in company stock.

Percentage Held by Insiders

2.40% of the stock of U.S. Physical Therapy is held by insiders.

Percentage Held by Institutions

U.S. Physical Therapy has minimal institutional ownership at this time.

Company Calendar

• Record date for 4/10 Dividend: 3/13/2026
• Ex-Dividend for 4/10 Dividend: 3/13/2026
• Dividend Payable: 4/10/2026
• Last Earnings: 5/06/2026
• Record date for 6/12 Dividend: 5/22/2026
• Ex-Dividend for 6/12 Dividend: 5/22/2026
• Today: 6/10/2026
• 16th Annual East Coast IDEAS Conference: 6/11/2026
• Dividend Payable: 6/12/2026
• Next Earnings (Estimated): 8/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED - OUTP/HM CRE
• Sub-Industry: Health Care Facilities
• Current Symbol: NYSE:USPH
• CIK: 885978
• Web: www.usph.com
• Phone: (713) 297-7000
• Fax: 713-297-7090
• Employees: 7,294
• Year Founded: 1990

Price Target and Rating

• Average Price Target for U.S. Physical Therapy: $97.50
• High Price Target: $102.00
• Low Price Target: $90.00
• Potential Upside/Downside: +57.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.86
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.50
• Trailing P/E Ratio: 123.74
• Forward P/E Ratio: 20.69
• P/E Growth: 1.69
• Net Income: $39.58 million
• Net Margins: 4.36%
• Pretax Margin: 8.93%
• Return on Equity: 8.81%
• Return on Assets: 3.57%

Debt

• Debt-to-Equity Ratio: 0.41
• Current Ratio: 1.19
• Quick Ratio: 1.19

Sales & Book Value

• Annual Sales: $780.99 million
• Price / Sales: 1.21
• Cash Flow: $4.17 per share
• Price / Cash Flow: 14.85
• Book Value: $31.37 per share
• Price / Book: 1.97

Miscellaneous

• Outstanding Shares: 15,220,000
• Free Float: 14,854,000
• Market Cap: $941.66 million
• Optionable: Optionable
• Beta: 1.16